These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 2548961)

  • 21. Altered cardiac bradykinin metabolism in experimental diabetes caused by the variations of angiotensin-converting enzyme and other peptidases.
    Adam A; Leclair P; Montpas N; Koumbadinga GA; Bachelard H; Marceau F
    Neuropeptides; 2010 Apr; 44(2):69-75. PubMed ID: 19836835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution and functional significance of cardiac angiotensin converting enzyme in hypertrophied rat hearts.
    Schunkert H; Jackson B; Tang SS; Schoen FJ; Smits JF; Apstein CS; Lorell BH
    Circulation; 1993 Apr; 87(4):1328-39. PubMed ID: 8384939
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Zinc metallopeptidase inhibitors. A novel antihypertensive treatment.
    Carretero OA; Scicli AG
    Hypertension; 1991 Sep; 18(3):366-71. PubMed ID: 1653769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of kinin in regulation of rat submandibular gland blood flow.
    Berg T; Carretero OA; Scicli AG; Tilley B; Stewart JM
    Hypertension; 1989 Jul; 14(1):73-80. PubMed ID: 2737739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Kinin receptors of the central nervous system of spontaneously hypertensive rats related to the pressor response to bradykinin.
    Martins DT; Fior DR; Nakaie CR; Lindsey CJ
    Br J Pharmacol; 1991 Aug; 103(4):1851-6. PubMed ID: 1655143
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinin antagonist reverses converting enzyme inhibitor-stimulated vascular prostaglandin I2 synthesis.
    Beierwaltes WH; Carretero OA
    Hypertension; 1989 Jun; 13(6 Pt 2):754-8. PubMed ID: 2544521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peptidase activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
    Linardi A; Panunto PC; Ferro ES; Hyslop S
    Biochem Pharmacol; 2004 Jul; 68(2):205-14. PubMed ID: 15193992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bradykinin metabolism pathway in the rat pulmonary circulation.
    Pesquero JB; Jubilut GN; Lindsey CJ; Paiva AC
    J Hypertens; 1992 Dec; 10(12):1471-8. PubMed ID: 1363432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kinins are involved in the antiproteinuric effect of angiotensin-converting enzyme inhibition in experimental diabetic nephropathy.
    Tschöpe C; Seidl U; Reinecke A; Riester U; Graf K; Schultheiss HP; Hilgenfeldt U; Unger T
    Int Immunopharmacol; 2003 Mar; 3(3):335-44. PubMed ID: 12639811
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Developmental regulation of ACE gene expression by endogenous kinins and angiotensin II.
    Yosipiv IV; el-Dahr SS
    Am J Physiol; 1995 Aug; 269(2 Pt 2):F172-9. PubMed ID: 7544538
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of kinins and angiotensin II on the regulation of papillary blood flow.
    Roman RJ; Kaldunski ML; Scicli AG; Carretero OA
    Am J Physiol; 1988 Oct; 255(4 Pt 2):F690-8. PubMed ID: 2845811
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Angiotensin I converting enzyme and kinin-hydrolyzing enzymes along the rabbit nephron.
    Marchetti J; Roseau S; Alhenc-Gelas F
    Kidney Int; 1987 Mar; 31(3):744-51. PubMed ID: 3033387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma kinin concentration in deoxycorticosterone-salt hypertension.
    Nakagawa M; Nasjletti A
    Hypertension; 1988 May; 11(5):411-5. PubMed ID: 3284820
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kinins, receptors, kininases and inhibitors--where did they lead us?
    Erdös EG; Marcic BM
    Biol Chem; 2001 Jan; 382(1):43-7. PubMed ID: 11258670
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of DL-2-mercaptomethyl-3-guanidinoethylthiopropanoic acid on the blood pressure response to vasoactive substances.
    Salgado HC; Carretero OA; Scicli AG; Murray RD
    J Pharmacol Exp Ther; 1986 Apr; 237(1):204-8. PubMed ID: 2420968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cooperative activation of TLR2 and bradykinin B2 receptor is required for induction of type 1 immunity in a mouse model of subcutaneous infection by Trypanosoma cruzi.
    Monteiro AC; Schmitz V; Svensjo E; Gazzinelli RT; Almeida IC; Todorov A; de Arruda LB; Torrecilhas AC; Pesquero JB; Morrot A; Bouskela E; Bonomo A; Lima AP; Müller-Esterl W; Scharfstein J
    J Immunol; 2006 Nov; 177(9):6325-35. PubMed ID: 17056563
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of a kinin antagonist on renal function in rats.
    Nakagawa M; Stewart JM; Vavrek RJ; Nasjletti A
    Am J Physiol; 1990 Mar; 258(3 Pt 2):F643-8. PubMed ID: 1690517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Depressor action of bradykinin agonists relative to metabolism by angiotensin-converting enzyme, carboxypeptidase N, and aminopeptidase P.
    Ahmad S; Ward PE
    Proc Soc Exp Biol Med; 1992 May; 200(1):115-21. PubMed ID: 1315058
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Involvement of the kallikrein-kinin system in the antihypertensive effect of the angiotensin converting enzyme inhibitors.
    Waeber B; Juillerat-Jeanneret L; Aubert JF; Schapira M; Nussberger J; Brunner HR
    Br J Clin Pharmacol; 1989; 27 Suppl 2(Suppl 2):175S-180S. PubMed ID: 2669913
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Some old and some new ideas on kinin metabolism.
    Erdös EG
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S20-4. PubMed ID: 1697356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.